Table 1.

Summary of participants’ characteristics

	Ipratropium bromide (N* = 7)
Age in Years [Mean (SD)]	62.1 (5.98)
Male [n (%)]	3 (43)
BMI (kg/m2) [Mean (SD)]	31.11 (3.191)
Height (cm) [Mean (SD)]	168.71 (16.039)
FVC [Mean (SD)]	2.58 (1.161)
% predicted FVC [Mean (SD)]	73.75 (12.863)
FEV1 [Mean (SD)]	2.12 (0.773)
% predicted FEV1 [Mean (SD)]	77.07 (11.256)

MDT diagnosis of study completers	Study completers (N = 5)
IPF/probable IPF [n (%)]	3 (60)
NSIP/fibrotic NSIP [n (%)]	2 (40)

BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume at 1 s, MDT multidisciplinary team, IPF idiopathic pulmonary fibrosis, NSIP non-specific interstitial pneumonia

Note 1: ^*One participant had to be re-enrolled

Note 2: As this was a non-quantitative, proof of concept study the impact of the participant’s characteristics was not designed to be taken into consideration